Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)
Clinical trial NCT02988362 · COMPLETED
Trial details
- NCT number
- NCT02988362
- Sponsor
- HanAll BioPharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-14
- Primary completion
- 2017-02-04
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.